The US Court of Appeals for the Federal Circuit held that the disclosure of an added function in the specification of a ...
Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement rejections under 35 U.S.C. §112(a). The USPTO routinely rejects claims as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results